If you bought XBI a year ago and held it, you are up roughly 65%. If you bought Direxion Daily S&P Biotech Bull 3X Shares (NYSEARCA:LABU) on the same day, you are up about 235%. That is the pitch for ...

Krystal Biotech (KRYS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its ...

The 552 million pounds ($747 million) raised by British biotechs in the first quarter of the year has been hailed as a “sign ...

Hemab Therapeutics Holdings Inc., a clinical-stage biotechnology company, is seeking to raise as much as $212 million in a US ...

Preview this article 1 min Investors that want to take the company private pointed at a recent successful IPO. Bay Area ...

After Xoma Royalty went on a dealmaking spree last year, the biotech royalty aggregator is now itself being bought out by its ...

Eli Lilly is continuing its Massachusetts shopping spree, picking up a Cambridge biotech focused on blood cancer treatments ...

April 27 (Reuters) - Ligand Pharmaceuticals will buy fellow biotechnology royalty aggregator XOMA Royalty for about $739 million in cash, the companies said on Monday. The deal adds more than 120 ...

A new therapy has the potential to cure hundreds of diseases — and even reverse aging. Credit...Photo illustration by Kensuke ...

April 27 (Reuters) - Drug developers Seaport Therapeutics and Hemab Therapeutics launched their U.S. initial public offerings ...

Lilly will buy Ajax, whose lead medicine is a once-daily pill in the early stages of study for a rare type of blood cancer.

UK biotech companies raised £552m in equity financing in Q1 2026, an 18% increase from the previous quarter, according to the BioIndustry Association. Venture capital inflows also rose 17% to £516m, ...